NexImmune Inc Ordinary Shares NEXI
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–2.17
- Bid/Ask
- $0.03 / $0.15
- Shares Outstanding
- 1.39M
- Market Cap
- $139.47
- Volume/Avg
- 1,486 / 567
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 50
- Website
- https://www.neximmune.com
Valuation
Metric | NEXI |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | NEXI |
|---|---|
Quick Ratio | 0.51 |
Current Ratio | 0.66 |
Interest Coverage | — |
Quick Ratio
NEXI
Profitability
Metric | NEXI |
|---|---|
Return on Assets (Normalized) | −130.58% |
Return on Equity (Normalized) | −249.29% |
Return on Invested Capital (Normalized) | −239.23% |
Return on Assets
NEXI
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|cgSYc!$ | LOCK|$j@? | $131B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|@Wshwzm | LOCK|?r<HD | $95B | |||
| Moderna Inc MRNA | LOCK|@yF%Jk | LOCK|<$ | $79B | |||
| argenx SE ADR ARGX | LOCK|%$@<vNb | LOCK|%xm | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|Q<@>jbv | LOCK|@>@ | $45B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|n####$p | LOCK|<j<q | $30B | |||
| Incyte Corp INCY | LOCK|zb#>w^ | LOCK|<B | $23B | |||
| BioNTech SE ADR BNTX | LOCK|<xQhyV | LOCK|^? | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|?>pxR&^ | LOCK|Stqx | $19B | |||
| BridgeBio Pharma Inc BBIO | LOCK|kfGJ#q | LOCK|dW | $15B |